Welcome to our dedicated page for BlackRock ESG Capital Allocation Term Trust SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock ESG Capital Allocation Term Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock ESG Capital Allocation Term Trust's regulatory disclosures and financial reporting.
Saba Capital Management, L.P., a more than ten percent owner of BlackRock ESG Capital Allocation Term Trust, reported two open-market sales of the trust’s common stock. It sold 34,797 shares on February 24, 2026 at an average price of $15.09 per share and 59,356 shares on February 25, 2026 at an average price of $15.27 per share.
After these transactions, Saba Capital indirectly held 23,575,057 shares of common stock, reflecting a net sale of 94,153 shares across the two days.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported open‑market sales of fund common stock. On February 19 and 20, 2026, it sold a total of 75,148 shares at prices of $15.03 and $15.07 per share. Following the latest transaction, it indirectly owned 23,669,210 shares of ECAT common stock.
Saba Capital Management and affiliates report a significant activist stake in BlackRock ESG Capital Allocation Term Trust, beneficially owning 23,744,358 common shares, or 23.9% of the class, based on 99,345,793 shares outstanding as of June 30, 2025.
Saba states that approximately $352,969,830 was paid to acquire these shares, funded by investor subscription proceeds, related capital appreciation, and ordinary-course margin borrowings. The shares are held in funds and accounts advised by Saba, which have rights to dividends and sale proceeds.
On February 18, 2026, a Saba-advised fund submitted a notice to nominate a slate of seven independent trustee candidates for election at the Issuer’s 2026 annual shareholder meeting, covering multiple board classes. Each nominee has entered into a nomination agreement with Saba that includes defense and indemnification related to potential litigation arising from their nominations.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open-market sales of common stock. It sold 113,401 shares on February 17 at $15.06 per share and 45,888 shares on February 18 at $15.11 per share, totaling 159,289 shares. After these indirect transactions, it reported owning 23,744,358 common shares.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported open-market sales of ECAT common stock. On February 12, 2026 it sold 234,005 shares at $15.47 per share, followed by 50,600 shares at $15.22 per share on February 13, 2026.
These transactions were reported as indirect ownership. After the February 13, 2026 sale, Saba Capital Management, L.P. reported beneficial ownership of 23,903,647 ECAT common shares.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported an open-market sale of 156,858 shares of common stock on February 11, 2026 at $15.60 per share. After this indirect sale, it beneficially owned 24,188,252 shares.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open-market sales of common stock. On February 9, 2026, it sold 96,973 shares at $15.55 per share. On February 10, 2026, it sold a further 64,101 shares at $15.60 per share.
After these transactions, Saba Capital Management, L.P. indirectly beneficially owned 24,345,110 shares of ECAT common stock.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported two open‑market sales of common stock. On February 5, 2026, it sold 131,090 shares at $15.11 per share. On February 6, 2026, it sold an additional 36,044 shares at $15.29 per share.
After these transactions, Saba Capital Management, L.P. beneficially owned 24,506,184 ECAT common shares, held indirectly. The filing reflects portfolio activity by a large shareholder rather than any change in the issuer’s business operations.
Saba Capital Management and affiliates report a significant ownership position in BlackRock ESG Capital Allocation Term Trust. They disclose beneficial ownership of 24,673,318 common shares, representing 24.84% of the fund’s outstanding shares, based on 99,345,793 shares outstanding as of June 30, 2025.
The filing, Amendment No. 27 to a Schedule 13D, is jointly made by Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein. All reported shares are held with shared voting and dispositive power through funds and accounts advised by Saba Capital.
Saba states that approximately $366,779,210 was paid to acquire these shares, using investor subscription proceeds, capital appreciation and margin borrowings in the ordinary course, with all recent trades executed in the open market. The amendment specifically updates information on funding, ownership details and the transaction schedule.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust, reported two sales of ECAT common stock. On February 3, 2026, it sold 143,707 shares at $15.38 per share, leaving 24,824,510 shares indirectly beneficially owned. On February 4, 2026, it sold another 151,192 shares at $15.28 per share, leaving 24,673,318 shares indirectly beneficially owned.